Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic.

Publication ,  Journal Article
Sadun, RE; Wells, MA; Balevic, SJ; Lackey, V; Aldridge, EJ; Holdgagte, N; Mohammad, S; Criscione-Schreiber, LG; Clowse, MEB; Yanamadala, M
Published in: BMJ Open Qual
2018

Teratogenic medications are often prescribed to women of childbearing age with autoimmune diseases. Literature suggests that appropriate use of contraception among these women is low, potentially resulting in high-risk unintended pregnancies. Preliminary review in our clinic showed suboptimal documentation of women's contraceptive use. We therefore designed a quality improvement initiative to target three process measures: documentation of contraception usage and type, contraception counselling and provider action after counselling. We reviewed charts of rheumatology clinic female patients aged 18-45 over the course of 10 months; for those who were on teratogenic medications (methotrexate, leflunomide, mycophenolate and cyclophosphamide), we looked for evidence of documentation of contraception use. We executed multiple plan-do-study-act (PDSA) cycles to develop and evaluate interventions, which centred on interprofessional provider education, modification of electronic medical record (EMR) templates, periodic provider reminders, patient screening questionnaires and frequent feedback to providers on performance. Among eligible patients (n=181), the baseline rate of documentation of contraception type was 46%, the rate of counselling was 30% and interventions after counselling occurred in 33% of cases. Averaged intervention data demonstrated increased provider performance in all three domains: documentation of contraception type increased to 64%, counselling to 45% and provider action to 46%. Of the patients with documented contraceptives, 50% used highly effective, 27% used effective and 23% used ineffective contraception methods. During this project, one unintentional pregnancy occurred in a patient on methotrexate not on contraception. Our interventions improved three measures related to contraception counselling and documentation, but there remains a need for ongoing quality improvement efforts in our clinic. This high-risk population requires increased provider engagement to improve contraception compliance, coupled with system-wide EMR changes to increase sustainability.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

BMJ Open Qual

DOI

EISSN

2399-6641

Publication Date

2018

Volume

7

Issue

3

Start / End Page

e000269

Location

England

Related Subject Headings

  • 4206 Public health
  • 4203 Health services and systems
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sadun, R. E., Wells, M. A., Balevic, S. J., Lackey, V., Aldridge, E. J., Holdgagte, N., … Yanamadala, M. (2018). Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic. BMJ Open Qual, 7(3), e000269. https://doi.org/10.1136/bmjoq-2017-000269
Sadun, Rebecca E., Melissa A. Wells, Stephen J. Balevic, Victoria Lackey, Erica J. Aldridge, Nicholas Holdgagte, Samya Mohammad, Lisa G. Criscione-Schreiber, Megan E. B. Clowse, and Mamata Yanamadala. “Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic.BMJ Open Qual 7, no. 3 (2018): e000269. https://doi.org/10.1136/bmjoq-2017-000269.
Sadun RE, Wells MA, Balevic SJ, Lackey V, Aldridge EJ, Holdgagte N, et al. Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic. BMJ Open Qual. 2018;7(3):e000269.
Sadun, Rebecca E., et al. “Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic.BMJ Open Qual, vol. 7, no. 3, 2018, p. e000269. Pubmed, doi:10.1136/bmjoq-2017-000269.
Sadun RE, Wells MA, Balevic SJ, Lackey V, Aldridge EJ, Holdgagte N, Mohammad S, Criscione-Schreiber LG, Clowse MEB, Yanamadala M. Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic. BMJ Open Qual. 2018;7(3):e000269.

Published In

BMJ Open Qual

DOI

EISSN

2399-6641

Publication Date

2018

Volume

7

Issue

3

Start / End Page

e000269

Location

England

Related Subject Headings

  • 4206 Public health
  • 4203 Health services and systems